ADP-TILIL7
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ADP-TILIL7, covering 2025-08-24 to 2025-08-24. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma [Phase 1]